Postprandial blood glucose response to a standard test meal in insulin-requiring patients with diabetes treated with insulin lispro mix 50 or human insulin mix 50

International Journal of Clinical Practice

Volumn 62, Issue 9, 2008, Pages 1344-1351

  Gao, Y ^b   Li, G ^c   Li, Y ^d   Guo, X ^b   Yuan, G ^b   Gong, Q ^c   Yan, L ^d   Zheng, Y ^a   Zhang, J ^a  

^a Eli Lilly Asia Inc   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

^c Sino Japan Friendship Hospital   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN LISPRO;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG FORMULATION; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEPATITIS E; HUMAN; HYPERTENSION; HYPERURICEMIA; HYPOGLYCEMIA; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORNING DOSAGE; NON INSULIN DEPENDENT DIABETES MELLITUS; PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINOPHARYNGITIS; TEST MEAL;

BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 49349106789     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01850.x     Document Type: Article

References (20)

1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006 29: S4 42.
2. American Diabetes Association. Postprandial blood glucose. Diabetes Care 2001 24: 775 8.
3. Monnier L, Lapinski H, Colette C. Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycaemia of type 2 diabetic patients: variations with increasing levels of HbA(1c). Diabetes Care 2003 26: 881 5.
4. Monnier L, Colette C, Dunseath GJ, Owens DR. The loss of postprandial glycemic control precedes stepwise deterioration of fasting with worsening diabetes. Diabetes Care 2007 30: 263 9.
5. Gin H, Rigalleau V. Post-prandial hyperglycaemia. Post-prandial hyperglycaemia and diabetes. Diabetes Metab (Paris) 2000 26: 265 72.
6. Smith NL, Barzilay JI, Shaffer D et al. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly. Arch Intern Med 2002 162: 209 16.
7. Torffvit O. Hyperglycaemia in diabetes: impact on nephropathy and cardiac risk. Nephrol Dial Transplant 2003 18: 1711 5.
8. International Diabetes Federation. Guideline for management of postmeal glucose. Brussels: International Diabetes Federation, 2007: 1 27.
9. Pan C. Diabetes care in China: meeting the challenge. Diabetes Voice 2005 50: 9 12.
10. Ministry of Health, People's Republic of China. National Nutrition Sampling Survey in 2002. http://www.moh.gov.cn/newshtml/11902.htm (accessed January 2008).
11. Roach P, Woodworth JR. Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures. Clin Pharmacokinet 2002 41: 1043 57.
12. Herz M, Arora V, Sun B, Ferguson SC, Bolli GB, Frier BM. Basal-bolus insulin therapy in type 1 diabetes: comparative study of pre-meal administration of a fixed mixture of insulin lispro (50%) and neutral protamine lispro (50%) with human soluble insulin. Diabet Med 2002 19: 917 23.
13. Roach P, Trautmann M, Arora V, Sun B, Anderson JH Jr, Mix50 Study Group. Improved postprandial blood glucose control and reduced nocturnal hypoglycaemia during treatment with two novel insulin-protamine formulations, insulin lispro Mix25 and insulin lispro Mix50. Clin Ther 1999 21: 523 34.
14. Boehm BO, Home PD, Behrend C, Kamp NM, Lindholm A. Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomised trial in type 1 and type 2 diabetic patients. Diabet Med 2002 19: 393 9.
15. Grizzle JE. The two-period change-over design and its use in clinical trials. Biometrics 1965 21: 467 80.
16. Nagelkerke NJD, Hart AAM, Oosting J. The two period binary response cross-over trial. Biom J 1986 28: 863 9.
17. Heise T, Weyer C, Serwas A et al. Time-action profiles of novel premixed preparations of insulin lispro and NPL insulin. Diabetes Care 1998 21: 800 3.
18. Schwartz S, Zagar AJ, Althouse SK, Pinaire JA, Holcombe JH. A single centre, randomised, double blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus. Clin Ther 2006 28: 1649 57.
19. Roach P, Arora V, Campaigne BN, Mattoo V, Rangwala S. the India Mix25/Mix50 study group. Humalog Mix50TM before carbohydrate-rich meals in type 2 diabetes mellitus. Diabetes Obes Metab 2003 5: 311 6.
20. Roach P, Yue L, Arora V for the Humalog Mix25 Study Group. Improved postprandial glycemic control during treatment with Humalog mix25, a novel protamine-based insulin lispro formulation. Diabetes Care 1999 22: 1258 61.